104 related articles for article (PubMed ID: 1448405)
1. Magnetic resonance imaging for the assessment of residual masses after treatment of non-Hodgkin's lymphomas.
Montalbán C; Rodríguez-García JL; Mazairas L; Ayala I; Marcos-Robles J
Postgrad Med J; 1992 Aug; 68(802):643-7. PubMed ID: 1448405
[TBL] [Abstract][Full Text] [Related]
2. 18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.
Mikhaeel NG; Timothy AR; O'Doherty MJ; Hain S; Maisey MN
Leuk Lymphoma; 2000 Nov; 39(5-6):543-53. PubMed ID: 11342337
[TBL] [Abstract][Full Text] [Related]
3. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
[TBL] [Abstract][Full Text] [Related]
4. [Gallium-67 scintigraphy in malignant lymphoma].
Cohen-Haguenauer O; Brice P; Gaci M; Le Pailleur A; Cheval E; Bris C; Frija J; Gisselbrecht C; Rain JD; Najean Y
Presse Med; 1993 Mar; 22(11):521-5. PubMed ID: 8511078
[TBL] [Abstract][Full Text] [Related]
5. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
6. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
[TBL] [Abstract][Full Text] [Related]
7. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.
Rahmouni A; Divine M; Lepage E; Jazaerli N; Belhadj K; Gaulard P; Golli M; Reyes F; Vasile N
Radiology; 2001 Jun; 219(3):621-8. PubMed ID: 11376245
[TBL] [Abstract][Full Text] [Related]
10. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
[TBL] [Abstract][Full Text] [Related]
11. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
[TBL] [Abstract][Full Text] [Related]
12. 18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.
Mikhaeel NG; Timothy AR; Hain SF; O'Doherty MJ
Ann Oncol; 2000; 11 Suppl 1():147-50. PubMed ID: 10707798
[TBL] [Abstract][Full Text] [Related]
13. Stage IE non-Hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases.
Miranda RN; Glantz LK; Myint MA; Levy N; Jackson CL; Rhodes CH; Glantz MJ; Medeiros LJ
Arch Pathol Lab Med; 1996 Mar; 120(3):254-60. PubMed ID: 8629900
[TBL] [Abstract][Full Text] [Related]
14. [Primary gastrointestinal non-Hodgkin's lymphoma in two Hungarian regions].
Kollár B; Rajnics P; Hunyady B; Zeleznik E; Jakucs J; Egyed M
Orv Hetil; 2009 Aug; 150(35):1649-53. PubMed ID: 19692309
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of residual mediastinal masses in treated Hodgkin's disease using MR imaging.
Nyman R; Forsgren G; Glimelius B
Acta Radiol; 1996 May; 37(3 Pt 1):323-6. PubMed ID: 8845262
[TBL] [Abstract][Full Text] [Related]
16. [Residual masses after chemotherapy of non-Hodgkin's lymphoma].
Trédaniel J; Lepage E; Frija J; Brice P; Gisselbrecht C; Boiron M
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):75-7. PubMed ID: 3387205
[TBL] [Abstract][Full Text] [Related]
17. Outcome of residual mediastinal masses of thoracic lymphomas in children: impact on management and radiological follow-up strategy.
Brisse H; Pacquement H; Burdairon E; Plancher C; Neuenschwander S
Pediatr Radiol; 1998 Jun; 28(6):444-50. PubMed ID: 9634459
[TBL] [Abstract][Full Text] [Related]
18. Molecular remission and non-Hodgkin's lymphoma.
Darby AJ; Johnson PW
Best Pract Res Clin Haematol; 2002 Sep; 15(3):549-62. PubMed ID: 12468405
[TBL] [Abstract][Full Text] [Related]
19. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
20. [Primary forms of extralymphatic non-Hodgkin's lymphoma].
Rusinowska Z; Kozaczka A; Wojnar J; Lalowicz I; Hołowiecka B; Cieśla J; Poborski W; Tomiczek A; Machalski M; Hołowiecki J
Pol Tyg Lek; 1996 May; 51(19-22):263-5. PubMed ID: 9289704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]